A Functional Variant rs2072915 is Associated with the Susceptibility and Mortality of Cervical Squamous Cell Carcinoma

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–527. doi:10.1056/NEJMoa021641
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244–265. doi:10.1136/jcp.55.4.244
   PubMed Web of Science ®Google Scholar
• Wang LY, Li RL, Guo M, Huang LX, Chen YM. Long noncoding RNA HULC promoter polymorphism rs1041279 is associated with an increased risk of cervical squamous cell carcinoma. Reprod Sci. 2020;27(1):93–99. doi:10.1007/s43032-019-00013-8
   Web of Science ®Google Scholar
• Mathonnet G, Fabian MR, Svitkin YV, et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science. 2007;317(5845):1764–1767. doi:10.1126/science.1146067
   PubMed Web of Science ®Google Scholar
• Li JH, Xiao X, Zhang YN, et al. MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Gynecol Oncol. 2011;120(1):145–151. doi:10.1016/j.ygyno.2010.09.009
   PubMed Web of Science ®Google Scholar
• Ke G, Liang L, Yang JM, et al. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Oncogene. 2013;32(25):3019–3027. doi:10.1038/onc.2012.323
   Web of Science ®Google Scholar
• Wu DW, Chuang CY, Lin WL, Sung WW, Cheng YW, Lee H. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting. Carcinogenesis. 2014;35(8):1823–1829. doi:10.1093/carcin/bgu102
   Web of Science ®Google Scholar
• Wang F, Liu M, Li X, Tang H. MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett. 2013;587(5):488–495. doi:10.1016/j.febslet.2013.01.016
   Web of Science ®Google Scholar
• Yu A, Zhang J, Mei Y, Zhong H, Chen S, Song Q. Correlation between single nucleotide polymorphisms of an miRNA binding site in the 3ʹUTR of PTEN and risk of cervical cancer among the Han Chinese. Genet Test Mol Biomarkers. 2020;24(7):381–389. doi:10.1089/gtmb.2019.0269
   Web of Science ®Google Scholar
• Huang J, Ni S, Li D, He Y. An insertion/deletion polymorphism at miRNA-122 binding site in the IL1A is associated with a reduced risk of cervical squamous cell carcinoma. Genet Test Mol Biomarkers. 2015;19(6):331–334. doi:10.1089/gtmb.2015.0015
   PubMed Web of Science ®Google Scholar
• Hang D, Zhou W, Jia M, et al. Genetic variants within microRNA-binding site of RAD51B are associated with risk of cervical cancer in Chinese women. Cancer Med. 2016;5(9):2596–2601. doi:10.1002/cam4.797
   Web of Science ®Google Scholar
• Guo X, Dong Z, Yamada S, et al. Association of Casp3 microRNA target site (1049216) SNP with the risk and progress of cervical squamous cell carcinoma. Int J Gynecol Cancer. 2017;27(2):206–213. doi:10.1097/IGC.0000000000000881
   Web of Science ®Google Scholar
• Zhou X, Shan L, Na J, Li Y, Wang J. The SNP rs4846048 of MTHFR enhances the cervical cancer risk through association with miR-522: a preliminary report. Mol Genet Genom Med. 2020;8(1):e1055. doi:10.1002/mgg3.1055
   Web of Science ®Google Scholar
• Shi Y, Li L, Hu Z, et al. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet. 2013;45(8):918–922. doi:10.1038/ng.2687
   PubMed Web of Science ®Google Scholar
• Miura K, Mishima H, Yasunami M, et al. A significant association between rs8067378 at 17q12 and invasive cervical cancer originally identified by a genome-wide association study in Han Chinese is replicated in a Japanese population. J Hum Genet. 2016;61(9):793–796. doi:10.1038/jhg.2016.50
   Web of Science ®Google Scholar
• Zheng Y, Nie P, Peng D, et al. m6AVar: a database of functional variants involved in m6A modification. Nucleic Acids Res. 2018;46(D1):D139–D145. doi:10.1093/nar/gkx895
   PubMed Web of Science ®Google Scholar
• Rui X, Xu Y, Jiang X, Ye W, Huang Y, Jiang J. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis. Cell Death Dis. 2018;9(12):1175. doi:10.1038/s41419-018-1228-z
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Sticht C, De la torre C, Parveen A, Gretz N. miRWalk: an online resource for prediction of microRNA binding sites. PLoS One. 2018;13(10):e0206239. doi:10.1371/journal.pone.0206239
   PubMed Web of Science ®Google Scholar
• Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103(5):368–383. doi:10.1093/jnci/djq562
   PubMedGoogle Scholar
• Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550–560. doi:10.1038/nrc2886
   PubMed Web of Science ®Google Scholar
• Lee SM, Lee JY, Choi JE, Lee SY, Park JY, Kim DS. Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathologic features. Cancer Genet Cytogenet. 2010;197(1):39–45. doi:10.1016/j.cancergencyto.2009.10.008
   Google Scholar
• Hoftijzer HC, Liu YY, Morreau H, et al. Retinoic acid receptor and retinoid X receptor subtype expression for the differential diagnosis of thyroid neoplasms. Eur J Endocrinol. 2009;160(4):631–638. doi:10.1530/EJE-08-0812
   Web of Science ®Google Scholar